Chemstar Indonesia Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Chemstar Indonesia Tbk. trades at Rp65 (market cap 110.5B, 17.69M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp256 (market cap 715.5B, 30.64M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is far larger — about 6.5× Chemstar Indonesia Tbk.'s market cap, and Charlie Hospital Semarang Tbk. is more actively traded (30.64M versus 17.69M). Which is the better fit depends on your goals.
| CHEM | RSCH | |
|---|---|---|
Market Cap | 110.5B | 715.5B |
Volume | 17.69M | 30.64M |
Lot | 176.91K | 306.41K |
Turnover | 1.16B | 7.98B |
Average Price | 65.44 | 260.34 |
Value | 1.16B | 7.98B |
Indicative Equilibrium Price | 65 | 256 |
Indicative Equilibrium Volume | 1.97K | 512 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Chemstar Indonesia Tbk (the “Company") was established based on Notarial Deed No. 7 datedJanuary 30, 2004 of Jusnita Gunawan, S.H. The Company started its commercial operations in 2004.
Read more on CHEM →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →